Country’s largest pharmaceutical company, Ranbaxy Laboratories Limited, announced that it has acquired manufacturing facilities that have the approval from the U.S. Food and Drug Administration (FDA).

Speaking on this, Malvinder Singh, CEO Ranbaxy Laboratories said, “We will transfer (production of) some products from India to America. Also, we are looking at making some acquisitions of manufacturing assets.”

He added that apart from US, his company is also keeping its options open to buy FDA-approved facilities from other countries.

The Sri Lanka Cricket (SLC) has officially announced the dates of India’s tour of Sri Lanka. SLC announced that Team India will land in Sri Lanka on January 26 to play a series of 5 ODIs and a Twenty20 international match – the first ODI will be played on January 28 in Dambulla.

Another ODI will be played at Dambulla on 30 Jan, while the remaining matches will be played in Colombo on February 2, 5 and 8. The Twenty20 international will be played in Colombo on Feb 10.

Radha Vinod Raju, Special DGP, J & K, has been named as the Director-General of the newly created National Investigation Agency (NIA).

A government spokesperson said that 59 year old Raju, a 1975-batch IPS officer, who heads the vigilance department in the militancy-hit state, will be the head of NIA till January 31, next year.

Speaking on this, an elated Raju said, “I am honoured to have been assigned with this task.”

“The job at hand is to establish the infrastructure, get suitable officers and start cracking. The rest will follow in due course,” added Raju.

A consultation paper on “Bandwidth required for ISPs for better connectivity and improved quality of service”, was released on Thursday by The Telecom Regulatory Authority of India (TRAI).

It is learnt that TRAI has issued this process to seek the views of the stakeholders so that it can develop a framework to fortify the existing regulations on quality of broadband service.

According to TRAI, there is a strong prerequisite to identify easily monitorable and enforceable QoS measures. This is mainly in regard to guarantee that a bare minimum (floor) bandwidth is on hand with service providers for provisioning of broadband and internet services with reasonable assured quality to its subscribers.

Aurobindo Pharma Ltd has received US Food and Drug Administration (USFDA) approval to manufacture and market generic versions of epilepsy drug levetiracetam in variable strengths.

Aurobindo will manufacture and market the tablet in dosages of 250 milligram, 500 mg, 750 mg and 1,000 mg and an oral solution in 100 mg per millilitre dose.

Levetiracetam is an anticonvulsant drug used for the treatment of epilepsy. It is S- enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.

Last year's runaway hit "Jodha Akbar" dominated the Indian Express Group's Nokia Star Screen Awards with the movie bagging honours including those for Best Actor, Best Director and Best Film. It was truly a nail-biting climax for the who’s who of the Hindi film industry as well as cine lovers on Wednesday night.

Superstar Hrithik Roshan, who played the role of Akbar in the film, walked away with the Best Actor award while Ashutosh Gowarikar was adjudged the Best Director.